POU2AF1 Antikörper (AA 148-255)
Kurzübersicht für POU2AF1 Antikörper (AA 148-255) (ABIN7870754)
Target
Alle POU2AF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 148-255
-
Verwendungszweck
- BOB.1 Antibody
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 148-255 from the human protein was used as the immunogen for the BOB.1 antibody.
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the BOB.1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the BOB.1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))
-
Andere Bezeichnung
- BOB.1
-
Hintergrund
- BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.
-
UniProt
- Q16633
Target
-